FTC Warns FDA That Biologic Suffixes Will Curb Competition

 
• By Dave Wallace
  
AirBalloons
FDA Biologic Naming Proposals Will Drag Down Biosimilars, The FTC Says • Source: Shutterstock

More from Regulation

More from Policy & Regulation